The effectiveness and safety of direct-acting antivirals for hepatitis C virus treatment: A single-center experience in Saudi Arabia

• Main Authors: Sumaiah J. Alarfaj (Author), Abdullah Alzahrani (Author), Anfal Alotaibi (Author), Malak Almutairi (Author), Mashael Hakami (Author), Njood Alhomaid (Author), Noori Alharthi (Author), Ghazwa B. Korayem (Author), Abdullah Alghamdi (Author)
• Format: Book
• Published: Elsevier, 2022-10-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: The introduction of direct-acting antivirals (DAA) to treat the hepatitis C virus (HCV) overcame many drawbacks of interferon-based therapy. DAA achieved sustained viral response (SVR) rates above 90% and overcame many drawbacks of pegylated interferon regimens.The HCV genotype (GT) dist...